A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer

Part of paid clinical trials in Denver, Colorado.

Sponsor
Genentech, Inc.
Study ID
NCT00047736
Phase
PHASE3
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to determine if Tarceva plus standard chemotherapy is more effective than standard chemotherapy alone in the treatment of lung cancer.

Key Dates

First listed
Oct 17, 2002
Start date
Jul 31, 2001
Status verified
Jun 2013
Completion
Jul 31, 2003

Study Design

Allocation
RANDOMIZED
Primary purpose
TREATMENT

Locations (2)

FacilityCityStateZIPSite coordinators
Multinational SitesDenverColorado--
Trial Information CenterDenverColorado--

Find similar trials in Denver, CO

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Multinational Sites· Denver, COTrial Information Center· Denver, CO

Related Studies